Biocryst Pharmaceuticals (BCRX) Change in Accured Expenses (2010 - 2022)
Biocryst Pharmaceuticals' (BCRX) quarterly Change in Accured Expenses came in at -$6.3 million in Q4 2022, down 2334.15% YoY from $284000.0 in Q4 2021, and down 200.0% on a QoQ basis from $6.3 million in Q3 2022.
Biocryst Pharmaceuticals (BCRX) Change in Accured Expenses (2010 - 2022) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 13 years of Change in Accured Expenses data on file, last reported at -$6.3 million in Q4 2022.
- Quarterly Change in Accured Expenses fell 2334.15% year-over-year to -$6.3 million in Q4 2022, while the trailing twelve-month figure through Sep 2022 was $6.6 million (up 6.06% YoY) and the FY2021 annual result came in at $4.2 million, down 38.4% from the prior year.
- Change in Accured Expenses fell to -$6.3 million in Q4 2022, from $6.3 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $6.3 million in Q3 2022 to a low of -$6.3 million in Q4 2022.
- A 5-year average of $763500.0 and a median of $1.4 million in 2018 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 1782.79% in 2022, down 2334.15% in 2022.
- Tracing BCRX's Change in Accured Expenses over 5 years: stood at $1.4 million in 2018, then increased by 4.22% to $1.5 million in 2019, then surged by 59.76% to $2.4 million in 2020, then slumped by 88.0% to $284000.0 in 2021, then plunged by 2334.15% to -$6.3 million in 2022.
- The last three Change in Accured Expenses figures came in at -$6.3 million (Q4 2022), $6.3 million (Q3 2022), and $284000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -6.35 Mn |
| Dec 31, 2022 | -6.35 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Dec 31, 2021 | 284,000.00 |
| Dec 31, 2021 | 284,000.00 |
| Sep 30, 2021 | 337,000.00 |
| Sep 30, 2021 | 337,000.00 |
| Jun 30, 2021 | 1.67 Mn |
| Jun 30, 2021 | 1.67 Mn |
| Mar 31, 2021 | 1.88 Mn |
| Mar 31, 2021 | 1.88 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Sep 30, 2020 | 1.50 Mn |
| Sep 30, 2020 | 1.50 Mn |
| Jun 30, 2020 | 1.43 Mn |
| Jun 30, 2020 | 1.43 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Mar 31, 2020 | 1.48 Mn |